He graduated from UCLA Department of Pediatrics completing his fellowship in pediatric gastroenterology in 2005. Dr. Ziring earned his B.S. in Zoology from UC Davis and his M.S. degrees in Applied Physiology and in Clinical Immunology as well as his MD from the Chicago Medical School. He has completed work on the National Institutes of Health sponsored K30 program in translational research.
Dr. Ziring serves as co-chair on the Medical Advisory Committee for the Southern California chapter of the Crohns and Colitis Foundation of America (CCFA). He also serves on the Pediatric IBD committee of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN). He has research grants supported by the CCFA and NIH. His laboratory research centers on the immunoregulation of the intestine and the modeling of human Inflammatory Bowel Disease (IBD).
Dr. Ziring is presently testing promising therapeutic compounds in mice for the treatment of human IBD, research that is also helping to understand key signals that immune cells use to control inflammation in the gut.